EGFR and breast cancer: This is the first study demonstrating in details that RA-XII could interfere PI3K/AKT, FAK/pSRC, MAPK and EGFR signaling pathways so as to inhibit breast cancer cell invasion in vitro and RA-XII inhibited tumour growth and metastasis in vivo.